Skip to main content

8 pharma billionaires increase wealth by $32 billion, 'enough' to vaccinate all in India

Cyrus Poonwalla, Pankaj Patel
By Jag Jivan   
At least nine people have become new billionaires since the beginning of the Covid pandemic, thanks to the excessive profits pharmaceutical corporations with monopolies on Covid vaccines are making, the People’s Vaccine Alliance (PVA), a global alliance advocating its availability free of charge to all people in all countries, has revealed ahead of the G20 leaders Global Health Summit.
A movement of health, humanitarian and human rights organisations, past and present world leaders, health experts, faith leaders and economists, which also advocates that Covid-19 vaccines should be manufactured rapidly and at scale free of intellectual property protections, PVA said, key members of the G20, who meet on Thursday, UK and Germany, “are blocking moves to boost supply” of the vaccines “to devastate lives in countries like India and Nepal, where only a tiny fraction of the population has been vaccinated.”
Meanwhile, PVA said in a statement, the nine new billionaires have amassed “net wealth of $19.3 billion, enough to fully vaccinate all people in low-income countries 1.3 times”, adding, “These countries have received only 0.2 per cent of the global supply of vaccines, because of the massive shortfall in available doses, despite being home to 10 per cent of the world’s population.”
“In addition”, it said, “Eight existing billionaires – who have extensive portfolios in the Covid-19 vaccine pharma corporations – have seen their combined wealth increase by $32.2 billion, enough to fully vaccinate everyone in India.”
Two of the eight are from India: Cyrus Poonawalla, founder, Serum Institute of India, whose wealth increased from $ 8.20 billion to $ 12.70 billion in a year; and Pankaj Patel of Cadila Healthcare, whose wealth increased from $ 2.90 billion to $ 5.00 billion in a year. Patel’s controls listed company “manufactures drugs to treat Covid-19 such as Remdesivir from Gilead, and its Covid-19 vaccine, ZyCoV-D, is undergoing clinical trials”, said PVA.
Campaigners from the People’s Vaccine Alliance – whose members include Global Justice Now, Oxfam and UNAIDS – reached this conclusion on the basis of an analysis of Forbes Rich List data to highlight the massive wealth being generated for a handful of people from vaccines which were largely public funded.
Anna Marriott, Oxfam’s Health Policy Manager, said: “What a testament to our collective failure to control this cruel disease that we quickly create new vaccine billionaires but totally fail to vaccinate the billions who desperately need to feel safe.”
She added, “These billionaires are the human face of the huge profits many pharmaceutical corporations are making from the monopoly they hold on these vaccines. These vaccines were funded by public money and should be first and foremost a global public good, not a private profit opportunity. We need to urgently end these monopolies so that we can scale up vaccine production, drive down prices and vaccinate the world.”
According to PVA, “Vaccine billionaires are being created as stocks in pharmaceutical firms rise rapidly in expectation of huge profits from the Covid-19 vaccines over which these firms have monopoly control”, warning, “These monopolies allow pharmaceutical corporations total control over the supply and price of vaccines, pushing up their profits while making it harder for poor countries, in particular, to secure the stocks they need.”

The PVA statement comes even as, earlier this month, US backed proposals by South Africa and India at the World Trade Organisation to temporarily break up these monopolies and lift the patents on Covid-19 vaccines. This move has the support of over 100 developing countries, and in recent days countries like Spain have also declared their support, as has the Pope and over 100 world leaders and Nobel laureates.
“Despite this, other rich nations, including UK and Germany, are still blocking the proposal, putting the interest of pharmaceutical companies over what’s best for the world. Italy, who are hosting the G20 Global Health Summit tomorrow, are continuing to sit on the fence on the issue, as are Canada and France”, it said.
Heidi Chow, Senior Policy and Campaigns Manager at Global Justice Now, said: “As thousands of people die each day in India, it is utterly repugnant that the UK, Germany and others want to put the interests of the billionaire owners of Big Pharma ahead of the desperate needs of millions.
Chow added, “The highly effective vaccines we have are thanks to massive amounts of taxpayers’ money so it can’t be fair that private individuals are cashing in while hundreds of millions face second and third waves completely unprotected. It is a sad indictment of the loyalties of some current governments that a handful of people working for pharmaceutical companies have been allowed to become billionaires off the back of publicly-funded efforts to end the pandemic.”
Topping the list of new billionaires who have cashed in on the success of Covid vaccines are the CEOs of Moderna and BioNTech, each with a wealth over $4 billion or more. The list includes two of Moderna’s founding investors and the company’s chair as well as the CEO of a company with a deal to manufacture and package the Moderna vaccine.
“This is despite the fact the vast majority of funding for the Moderna vaccine was paid for by taxpayers. The final three new vaccine billionaires are all co-founders of the Chinese vaccine company CanSino Biologics”, the statement said.
Winnie Byanyima, Executive Director of UNAIDS, said: “While the companies making massive profits from COVID vaccines are refusing to share their science and technology with others in order to increase the global vaccine supply, the world continues to face the very real risk of mutations that could render the vaccines we have ineffective and put everyone at risk all over again.”
She added, “The pandemic has come at a terrible human cost, so it is obscene that profits continue to come before saving lives.”
Figures for vaccinating all poorest countries are analysed by PVA based on countries defined as ‘Low Income’, for which the population is 775,710,612 (according to UN Population 2020). The average vaccine cost, $19, is based on the average mid-range cost per course of vaccination of the 5 leading vaccine producers.
“However”, it said, “The prices should be far lower and the $19 is for illustration purposes and is in no way an endorsement of these unacceptably high prices. The wealth of the new billionaires could vaccine all low-Income countries 1.3 times.”
For instance, it said, “The population of India (according to UN Population 2020) is 1.38 billion and the increase in wealth of the 8 existing billionaires could vaccine everyone in India 1.2 times. All figures based on a two-dose regimen (click here for vaccine doses in low income countries data).

Comments

TRENDING

Countrywide protest by gig workers puts spotlight on algorithmic exploitation

By A Representative   A nationwide protest led largely by women gig and platform workers was held across several states on February 3, with the Gig & Platform Service Workers Union (GIPSWU) claiming the mobilisation as a success and a strong assertion of workers’ rights against what it described as widespread exploitation by digital platform companies. Demonstrations took place in Delhi, Rajasthan, Karnataka, Maharashtra and other states, covering major cities including New Delhi, Jaipur, Bengaluru and Mumbai, along with multiple districts across the country.

Swami Vivekananda's views on caste and sexuality were 'painfully' regressive

By Bhaskar Sur* Swami Vivekananda now belongs more to the modern Hindu mythology than reality. It makes a daunting job to discover the real human being who knew unemployment, humiliation of losing a teaching job for 'incompetence', longed in vain for the bliss of a happy conjugal life only to suffer the consequent frustration.

CFA flags ‘welfare retreat’ in Union Budget 2026–27, alleges corporate bias

By Jag Jivan  The advocacy group Centre for Financial Accountability (CFA) has sharply criticised the Union Budget 2026–27 , calling it a “budget sans kartavya” that weakens public welfare while favouring private corporations, even as inequality, climate risks and social distress deepen across the country.

From water scarcity to sustainable livelihoods: The turnaround of Salaiya Maaf

By Bharat Dogra   We were sitting at a central place in Salaiya Maaf village, located in Mahoba district of Uttar Pradesh, for a group discussion when an elderly woman said in an emotional voice, “It is so good that you people came. Land on which nothing grew can now produce good crops.”

Paper guarantees, real hardship: How budget 2026–27 abandons rural India

By Vikas Meshram   In the history of Indian democracy, the Union government’s annual budget has always carried great significance. However, the 2026–27 budget raises several alarming concerns for rural India. In particular, the vague provisions of the VBG–Ram Ji scheme and major changes to the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGA) have put the future of rural workers at risk. A deeper reading of the budget reveals that these changes are not merely administrative but are closely tied to political and economic priorities that will have far-reaching consequences for millions of rural households.

Penpa Tsering’s leadership and record under scrutiny amidst Tibetan exile elections

By Tseten Lhundup*  Within the Tibetan exile community, Penpa Tsering is often described as having risen through grassroots engagement. Born in 1967, he comes from an ordinary Tibetan family, pursued higher education at Delhi University in India, and went on to serve as Speaker of the Tibetan Parliament-in-Exile from 2008 to 2016. In 2021, he was elected Sikyong of the Central Tibetan Administration (CTA), becoming the second democratically elected political leader of the administration after Lobsang Sangay. 

'Gandhi Talks': Cinema that dares to be quiet, where music, image and silence speak

By Vikas Meshram   In today’s digital age, where reels and short videos dominate attention spans, watching a silent film for over two hours feels almost like an act of resistance. Directed by Kishor Pandurang Belekar, “Gandhi Talks” is a bold cinematic experiment that turns silence into language and wordlessness into a powerful storytelling device. The film is not mere entertainment; it is an experience that pushes the viewer inward, compelling reflection on life, values, and society.

Frugal funds, fading promises: Budget 2026 exposes shrinking space for minority welfare

By Syed Ali Mujtaba*  The Ministry of Minority Affairs was established in 2006 during the tenure of Prime Minister Manmohan Singh, following the findings of the Sachar Committee, which documented that Muslims were among the most educationally and economically disadvantaged communities in India. The ministry was conceived as a corrective institutional response to deep structural inequalities faced by religious minorities, particularly Muslims, through focused policy interventions.

From Puri to the State: How Odisha turned the dream of drinkable tap water into policy

By Hans Harelimana Hirwa, Mansee Bal Bhargava   Drinking water directly from the tap is generally associated with developed countries where it is considered safe and potable. Only about 50 countries around the world offer drinkable tap water, with the majority located in Europe and North America, and a few in Asia and Oceania. Iceland, Switzerland, Finland, Germany, and Singapore have the highest-quality tap water, followed by Canada, New Zealand, Japan, the USA, Australia, the UK, Costa Rica, and Chile.